Screening and surveillance for Barrett esophagus.
作者信息
Lochhead Paul, Chan Andrew T
机构信息
Gastrointestinal Research Group, Division of Applied Medicine, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts4Division of Gastroenterology, Massachusetts General Hospital, Boston.
出版信息
JAMA Intern Med. 2015 Feb;175(2):159-60. doi: 10.1001/jamainternmed.2014.6983.
Abstract
摘要
相似文献
1
Screening and surveillance for Barrett esophagus.巴雷特食管的筛查与监测
JAMA Intern Med. 2015 Feb;175(2):159-60. doi: 10.1001/jamainternmed.2014.6983.
2
Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.胃食管反流病、巴雷特食管和食管腺癌。
Arch Intern Med. 2004 Jul 26;164(14):1482-8. doi: 10.1001/archinte.164.14.1482.
3
How far to go? Screening and surveillance in Barrett's esophagus.路在何方？巴雷特食管的筛查与监测
Am J Manag Care. 2001 Feb;7(1 Suppl):S19-26.
4
Barrett's esophagus and adenocarcinoma.巴雷特食管与腺癌。
Annu Rev Med. 1987;38:477-92. doi: 10.1146/annurev.me.38.020187.002401.
5
[Importance of the Barrett esophagus in the development of esophageal adenocarcinoma].[巴雷特食管在食管腺癌发生发展中的重要性]
Med Arh. 2002;56(1 Suppl 1):7-9.
6
Screening for Barrett's esophagus.巴雷特食管的筛查
Rev Gastroenterol Disord. 2002;2 Suppl 2:S25-9.
7
Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?对巴雷特食管和食管腺癌进行筛查能延长生存期吗？
J Clin Oncol. 2005 Jul 10;23(20):4478-82. doi: 10.1200/JCO.2005.19.059.
8
Screening for Barrett's esophagus.巴雷特食管的筛查
Am Fam Physician. 2004 May 1;69(9):2061-3.
9
[Barrett esophagus: features of structure and diagnostic tactics].[巴雷特食管：结构特征与诊断策略]
Klin Khir. 1996(5):46-9.
10
Barrett's esophagus and cancer. Preface.巴雷特食管与癌症。前言。
Surg Oncol Clin N Am. 2009 Jul;18(3):xv-xvi. doi: 10.1016/j.soc.2009.04.003.
引用本文的文献
1
ADENOCARCINOMA AND DYSPLASIA IN BARRETT ESOPHAGUS: CRITICAL ANALYSIS OF RISK FACTORS AND SURVEILLANCE PROTOCOLS.巴雷特食管中的腺癌和异型增生：危险因素和监测方案的批判性分析。
Arq Bras Cir Dig. 2024 Nov 15;37:e1826. doi: 10.1590/0102-6720202400033e1826. eCollection 2024.
2
Nanofiber capsules for minimally invasive sampling of biological specimens from gastrointestinal tract.用于微创从胃肠道中采集生物样本的纳米纤维胶囊。
Acta Biomater. 2022 Jul 1;146:211-221. doi: 10.1016/j.actbio.2022.04.045. Epub 2022 May 2.
3
Barrett's esophagus: novel strategies for screening and surveillance.巴雷特食管：筛查与监测的新策略
Ther Adv Chronic Dis. 2019 Mar 26;10:2040622319837851. doi: 10.1177/2040622319837851. eCollection 2019.
4
Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.甲基化panel 是内镜活检和非内镜细胞学标本中 Barrett 食管的诊断生物标志物。
Gut. 2018 Nov;67(11):1942-1949. doi: 10.1136/gutjnl-2017-314026. Epub 2017 Oct 30.
5
Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005-2013) for Barrett's Esophagus.巴雷特食管实践指南（2005 - 2013年）中科学证据质量及利益冲突的系统分析与批判性评估
Dig Dis Sci. 2016 Oct;61(10):2812-2822. doi: 10.1007/s10620-016-4222-2. Epub 2016 Jun 15.
本文引用的文献
1
Medical professional liability claims related to esophageal cancer screening.与食管癌筛查相关的医疗职业责任索赔。
JAMA. 2014 Oct 1;312(13):1348-9. doi: 10.1001/jama.2014.7960.
2
Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study.巴雷特食管的监测与食管腺癌死亡率：一项基于人群的队列研究。
Am J Gastroenterol. 2014 Aug;109(8):1215-22. doi: 10.1038/ajg.2014.156. Epub 2014 Jul 1.
3
Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.射频消融与内镜监测治疗 Barrett 食管伴低级别上皮内瘤变：一项随机临床试验。
JAMA. 2014 Mar 26;311(12):1209-17. doi: 10.1001/jama.2014.2511.
4
Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus.内镜监测非异型增生性 Barrett 食管的成本效益。
Gastrointest Endosc. 2014 Feb;79(2):242-56.e6. doi: 10.1016/j.gie.2013.07.046. Epub 2013 Sep 27.
5
Trends in esophageal adenocarcinoma incidence and mortality.食管腺癌发病率和死亡率的趋势。
Cancer. 2013 Mar 15;119(6):1149-58. doi: 10.1002/cncr.27834. Epub 2012 Dec 11.
6
Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.内镜和非内镜细胞刷筛查 Barrett 食管的健康获益和成本效益。
Gastroenterology. 2013 Jan;144(1):62-73.e6. doi: 10.1053/j.gastro.2012.09.060. Epub 2012 Oct 3.
7
Incidence of adenocarcinoma among patients with Barrett's esophagus.巴雷特食管患者腺癌的发病率。
N Engl J Med. 2011 Oct 13;365(15):1375-83. doi: 10.1056/NEJMoa1103042.
8
American Gastroenterological Association technical review on the management of Barrett's esophagus.美国胃肠病学会关于巴雷特食管管理的技术审查
Gastroenterology. 2011 Mar;140(3):e18-52; quiz e13. doi: 10.1053/j.gastro.2011.01.031.
9
The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data.美国 Barrett 食管的流行率：通过 SEER 数据证实的模拟模型估计。
Dis Esophagus. 2010 Aug;23(6):451-7. doi: 10.1111/j.1442-2050.2010.01054.x. Epub 2010 Mar 26.
10
Is there publication bias in the reporting of cancer risk in Barrett's esophagus?巴雷特食管癌症风险报告中是否存在发表偏倚？
Gastroenterology. 2000 Aug;119(2):333-8. doi: 10.1053/gast.2000.9302.
Zotero 插件